We re-engineered the immunoglobulin rearrangements from clonally expanded CSF B cells of three Multiple Sclerosis patients as Fab fragments, and used three methods to test for their antigen (Ag) specificity. Nine out of ten Fab fragments were reactive to Myelin Basic Protein (MBP). The one Fab that did not react to MBP was a product of receptor editing. Two of the nine MBP reactive Fabs were also reactive to GFAP and CNPase, indicating that these clones were polyreactive. Targeting the mechanisms that allow these self-reactive B cells to reside in the CSF of MS patients may prove to be a potent immunotherapeutic strategy.
Introduction
Multiple Sclerosis (MS) is considered an inflammatory, demyelinating disease of the central nervous system (CNS). It is suspected that MS is an autoimmune disease involving immune responses directed against self-myelin associated antigens (Ag). There is substantial evidence that humoral immune components in the CNS may be involved in the development and perpetuation of MS (in at least a subset of patients)(reviewed in (Antel, 1999; Archelos et al., 2000; Cross et al., 2001; Martin and Monson, 2007; O'Connor et al., 2001) ). More recently, several groups have demonstrated extensive clonal expansion of B cells in the CSF of MS patients (Blalock et al., 1999; Columbo et al., 2000; Owens et al., 2003; Qin et al., 1998; Ritchie et al., 2004) . Our laboratory has also demonstrated that B cell clonal expansion and intraclonal diversity was evident in all 5 MS patients analyzed, even those that had been recently diagnosed with MS (Monson et al., 2005a) . Taken together, these data strongly suggest that B cells in the CNS of MS patients may be contributing to the pathogenesis of MS by responding to antigens in that compartment. The focus of this study was to determine whether clonally expanded B cells in the CSF of MS patients are reactive to Ag components of the CNS, and are thus self-reactive.
Our laboratory has also demonstrated that several of the clonally expanded CSF B cells from these MS patient repertoires had undergone receptor editing. Typically, B cells in the bone marrow undergo receptor editing in an attempt to escape self-reactivity (Casellas et al., 2001; Edry and Melamed, 
